ToolGen, 10 Billion Won Osong R&D Center New Construction Project

[Asia Economy Reporter Minji Lee] ToolGen announced on the 16th that it has decided to construct the Osong R&D Center with a budget of 10 billion KRW. This corresponds to 10.12% of its equity capital.

The company stated, "This is to carry out the CRISPR gene-editing R&D project and to create network synergy among clusters within the Osong Advanced Medical Complex." The investment period is until December 16, 2023.